The Role of Pharmacists in the Fight Against COVID-19
COVID-19 is a respiratory infection caused by SARSCoV-2, a newly identified coronavirus. The disease has
quickly spread throughout the world and was declared a pandemic. Older people and those with comorbid
conditions carry the highest burden of morbidity and mortality associated with COVID-19. As the most
accessible health care professionals, community and ambulatory care pharmacists are well positioned to
respond to this public health crisis by testing eligible patients—recently allowed by federal regulation–
counseling them on treatment options for symptomatic relief, reinforcing prevention measures, and managing
drug shortages. Hospital pharmacists also play an important role by assisting prescribers in selecting the
best treatment regimens for patients, evaluating and securing investigational agents, developing criteria for
drug use, mitigating drug shortages, and preserving personal protective equipment. In addition, long-term
care pharmacists are instrumental in optimizing medication management and developing policies to reduce the
risk of COVID-19 transmission among vulnerable residents.
Keywords: COVID-19; PHARMACIST' ROLE; PUBLIC HEALTH; SARS-CoV-2
Document Type: Commentary
Publication date: 01 July 2020
- The Senior Care Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Senior Care Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- ">
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content